SON LOS (LA TECNOLOGIA DE ) MONOCLONALES DE DON TRUMP
QUE LLEGARON A PROHIBIR Y AMENAZAR A LOS MEDIOS QUE LO RECETASEEN
Y QUE DABAN GRATIS EN CARPAS ..
You must be registered for see images
SI NO SE PRESENTABA EL FBI A CLAUSULARLAS ENCHIDOS DE REPRUEBO Y ANTI TRUMPISMO
EY! A EL LE FUNCIONA.
USARLOS ES = VOTAR A TRUMP
¡ASI QUE DOBLE BENEFICIO ! SALUTIFERO Y POLITICO
AQUI SU EXCELENTISMO DON DONALDO J. TRUMP FIRMADO LA PODEROSA ORDEN EXECUTIVE QUE DEBERIA HABER GARANTIZADO ASISTENCIA GRATUITA CON ESTA TECNOLOGIA
DE NO SER POR EL FBI
You must be registered for see images
You must be registered for see images
Tienes que estar registrado para ver este contenido
Monoclonal antibody treatment orders rapidly increasing in ELbichito surge states
It's overwhelmingly going to area areas where ICU capacities are most strained.
By
Tienes que estar registrado para ver este contenido
August 21, 2021, 11:12 AM
You must be registered for see images
Florida Governor, Ron DeSantis holds a press conference to announce the opening of a monoclonal antibody treatment site to help ELbichito-19 patients recover at Camping World Stadium in Orlando.
Paul Hennessy | LightRocket | Getty Images
Florida and Texas are opening free monoclonal antibody centers to treat a surge in Elbichito-19 patients in both states, hoping early intervention will help keep people out of the hospitals and save more lives — even as the governors of both states fight local officials on mask and vaccine mandates.
Texas is setting up nine antibody infusion centers, Gov. Greg Abbott announced Friday, while Florida launched its fifth site Wednesday. With the delta variant surging, more than 46% of Texas’ intensive care beds and over half of Florida’s ICU capacity were filled with cobi19 patients as of Thursday, compared with 27% nationwide, according to the Department of Health and Human Services.
“What puts you in the hospital is the inflammation. People get inflammation in their lungs,” Dr. Arturo Casadevall, chair of Molecular Microbiology and Immunology at Johns Hopkins University’s Bloomberg School of Public Health, told CNBC in an interview. “So what these antibodies do is, if you give them to a patient early, they will neutralize the bicho.”
Abbott is getting firsthand experience with the treatment. His office announced Tuesday that he’s receiving Regeneron’s monoclonal antibody treatment after he
Tienes que estar registrado para ver este contenido
, despite being fully vaccinated.
